Skip to main content
OpenTrials

Clinical trial condition

Solid Tumor, Adult

Explore clinical trials studying Solid Tumor, Adult. Study availability and eligibility vary by location and protocol.

199 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumor, Adult trial results

Recruiting

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

NCT04219254

Conditions
Solid Tumor, Adult
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • HealthPartners Institute - Regions Cancer Care Center, Saint Paul, Minnesota, United States
  • Oklahoma University , Stephenson Cancer Center Oklahoma City, Oklahoma, United States
View all 26 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Conditions
Adenoma, Adnexal Diseases, Bronchial Neoplasms, +61 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
View Trial Details
Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

NCT06917079

Conditions
Advanced Lung Carcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +34 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

NCT03686124

Conditions
Adnexal Diseases, Cancer, Disease Attributes, +35 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 21 locations
View Trial Details
Recruiting

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

NCT07020221

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details

Related conditions